CA Patent

CA3069135A1 — Bioerodible drug delivery implants

Assigned to Hera Health Solutions Inc · Expires 2019-01-17 · 7y expired

What this patent protects

Disclosed herein are bioerodible drug delivery devices including one or more active agents, and related methods. The devices are useful for administering a wide variety of agents over prolonged periods of time.

USPTO Abstract

Disclosed herein are bioerodible drug delivery devices including one or more active agents, and related methods. The devices are useful for administering a wide variety of agents over prolonged periods of time.

Drugs covered by this patent

Patent Metadata

Patent number
CA3069135A1
Jurisdiction
CA
Classification
—
Expires
2019-01-17
Drug substance claim
No
Drug product claim
No
Assignee
Hera Health Solutions Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.